Get started
Author

YUTA MIYASHI

Heterogeneity of Tumor Glucose Metabolism in Schwannomas Between Trunk and Extremities: An Imaging Study
2025 · YUTA MIYASHI, HIROMICHI OSHIRO, et al. · In Vivo · 2
PDF
Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal Fibroblasts
2025 · YOHEI ASANO, QINGHONG HAN, et al. · Anticancer Research · 2
Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of Cancer
2025 · BYUNG MO KANG, QINGHONG HAN, et al. · Anticancer Research · 2
PDF
The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human Fibroblasts
2025 · YOHEI ASANO, QINGHONG HAN, et al. · Anticancer Research · 2
PDF
Relationship Between18F-FDG-PET/CT-derived Tumor Glucose Metabolic Activity, Nutritional Risk, and Survival in Patients With Soft-tissue Sarcoma
2024 · HIROMICHI OSHIRO, KOHEI MIZUTA, et al. · Anticancer Research · 2
The Glucose and Glutamine Requirements of Cancer and Normal Cells Do Not Distinguish Them, in Contrast to Their Methionine Requirement, Suggesting the Warburg Effect Is Not a Cancer Paradigm
2026 · YUTA MIYASHI, KOHEI MIZUTA, et al. · Anticancer Research · 1
PDF
Methionine Restriction Alone Induces T-cell-mediated Immunotherapy of Osteosarcoma in a Syngeneic Mouse Model
2026 · KOHEI MIZUTA, YUTARO KUBOTA, et al. · In Vivo · 1
PDF
Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal Cells
2026 · BYUNG MO KANG, QINGHONG HAN, et al. · Cancer Diagnosis & Prognosis · 1
PDF
Methionine Restriction, Not Cysteine Restriction, Is a Cancer-specific Vulnerability
2025 · YUTA MIYASHI, KOHEI MIZUTA, et al. · Anticancer Research · 1
PDF
Effect of Recombinant Methioninase Dose and Timing on the Selective and Precise Elimination of Cancer Cells from Co-Cultured Normal Cells and on Methionine-dependent Rescue of Cancer Cells
2025 · JINSOO KIM, QINGHONG HAN, et al. · Anticancer Research · 1
PDF
Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal Fibroblasts
2025 · YOHEI ASANO, QINGHONG HAN, et al. · Anticancer Research · 1
PDF
Simultaneous Targeting of Multiple Hallmarks of Cancer With Recombinant Methioninase, Rapamycin and Chloroquine Is Specific and Synergistic to MiaPaCa-2 Pancreatic-Cancer Cells in Contrast to Hs-27 Normal Fibroblasts
2025 · JINSOO KIM, QINGHONG HAN, et al. · Anticancer Research · 1
PDF
Eradication of Extensive Lymph‐Node, Bone and Pleural Metastases of a Breast‐Cancer Patient Treated With Radiation, Immunotherapy and Oral Recombinant Methioninase
2025 · YOHEI ASANO, TOSHIHIKO SATO, et al. · Cancer Diagnosis & Prognosis · 1
PDF
Combinations of Salmonella typhimurium A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal Fibroblasts
2025 · JINSOO KIM, QINGHONG HAN, et al. · Anticancer Research · 1
PDF
Direct comparison of serine restriction on the viability of normal and cancer cells demonstrates that methionine restriction is more cancer specific
2026 · Yuta Miyashi, Tomoyuki Ishiguro, et al. · Frontiers in Oncology
Synergy of KRAS-inhibitor Daraxonrasib Combined With Recombinant Methioninase on Pancreatic-cancer Cells But Not Normal Cells
2026 · JINSOO KIM, QINGHONG HAN, et al. · Anticancer Research
The Phosphatidylinositol 3-Kinase (PI3K) Inhibitor Inavolisib Has Breast-cancer Synergy Combined With Recombinant Methioninase But Not on Normal Cells
2026 · JINSOO KIM, QINGHONG HAN, et al. · In Vivo
Synergy of a Low-methionine Diet and Reduced-dose Cisplatinum Eradicates Experimental Lung-cancer Bone Metastases in a Nude-mouse Model
2026 · YOHEI ASANO, KOHEI MIZUTA, et al. · In Vivo
Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cells
2026 · Jinsoo Kim, Qinghong Han, et al. · Frontiers in Oncology
PDF
The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal Fibroblasts
2026 · JINSOO KIM, QINGHONG HAN, et al. · Cancer Diagnosis & Prognosis
PDF
Chemotherapy in Combination With Methionine Restriction Induced A Complete Response in a Patient With Recurrent Metastatic Tongue Squamous-Cell Carcinoma
2026 · TOMOYUKI ISHIGURO, TOSHIHIKO SATO, et al. · Cancer Diagnosis & Prognosis
PDF
Sulfasalazine an Inhibitor of System x C − (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine Restriction
2026 · JINSOO KIM, QINGHONG HAN, et al. · Anticancer Research
Ultra-low Concentrations of Cisplatinum Down to the IC 10 in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In Vivo
2026 · YOHEI ASANO, QINGHONG HAN, et al. · In Vivo
PDF
Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine Dependence
2026 · YUTA MIYASHI, KOHEI MIZUTA, et al. · Anticancer Research
Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase In Vitro
2026 · JINSOO KIM, QINGHONG HAN, et al. · Anticancer Research
Works count: 30
Citation count: 19
H-index: 2
I10-index:
Year
Topic
Type